From the Sector

HeiQ announces that its HeiQ Allergen* Tech has powered the award-winning product, Purotex+ from BekaertDeslee. The innovative solution for mattress ticking won the Interzum Award in the category "High Product Quality", being one of the six prizes given to BekaertDeslee.

Purotex+ powered by HeiQ Allergen* Tech is a solution for reducing exposure to allergens in bedding. The technology uses active probiotics to reduce exposure to allergens, including house dust mite matter, and pet allergens. HeiQ Allergen* Tech has received the Seal of Approval by Allergy UK, and independent testing has shown that it reduces exposure to inanimate allergens by up to 96.6%, making it a highly effective solution for allergy sufferers.

The Interzum Award recognizes exceptional design and innovation in the furniture production industry. Purotex+ was selected for the award from a field of 280 submissions from 25 countries. The jury praised the product's design, innovative features, and its contribution to improving the quality of life for people with allergies.

*Inanimate allergens such as house dust mite matter & pet allergens.

A total of 20 European fashion and design schools took part in the 2nd “Fashioning Sustainability” competition organized by Freudenberg Performance Materials together with Macpi and Bemberg™ by Asahi Kasei, two co-branding partners in the textile industry.

Freudenberg invited talented young designers to create and submit their ideas for sustainable clothing. The initiative aims to show that sustainability is a key factor in the fashion industry.

Two of the most innovative outfits from each school were selected for the final round and presented to an international jury at the “Bagni Misteriosi” event location in Milan in May. Fashion design experts and opinion leaders as well as journalists were invited to select the most sustainable designs in the categories of “Technology” and “Design”.

The winners
First place in the “Technology” category went to Judith Marquant while the second to Jagoda Sokolowska, both students of the fashion school Esmod in Paris. Ilaria De Martino, from the fashion institute Modartech, Italy, and Xiaodan Liao from Polimoda, Italy, were awarded first and second place in the “Design” category. The first-place winners received €2,000, while the second places won €1,000.

All participants benefited from the platform to network with leading players in the garment industry and learn more about concrete steps for embracing sustainability. Creating true sustainability in the fashion industry means reducing the material flow of clothing, addressing both sustainable production and consumption.

Members of the Jury:
Cristiano Zanetti, Sales Director Italy, Freudenberg Performance Materials
Maurizio Cazzin, Male Modeller, Maison Giorgio Armani
Riccardo Bullio, Apparel Industrial Division Director, Dolce & Gabbana
Caterina Cuoghi, Industrial Director, Area NYC
Simone Bigi, Style and Product Office Manager FAY line, Gruppo TOD’S
Roberto Cibin, Model and Pattern Development Manager, Caruso
Bruno Landi, Sales Director, Vitale Barberis Canonico
Luisella Allegretti, Pattern Designer Boss MW Business Specialist, Hugo Boss
Eugenio Balordi, Product Manager, Maison Margiela
Ettore Pellegrini, Sales and Marketing Manager, Asahi Kasei Fibers Italia

• 1Q23 Performance Summary
• Revenue of US$4B, an increase of 3% QoQ and a decline of 9% YoY
• Reported EBITDA of US$301M, an increase of 269% QoQ and decrease of 62% YOY
• Operating cash flows of US$201M
• Net Operating Debt to Equity of 1.00x
• Reported EPS of THB 0.14

Indorama Ventures Public Company Limited (IVL), a global sustainable chemical producer, reported improved quarterly earnings as headwinds continue to ease from the previous quarter’s peaks, although still below normalized levels. The company continues to focus on enhancing its global competitiveness as the full benefit of China’s reopening spurs volumes through the year, and as volatile energy costs and the destocking trend by customers begin to normalize.

Indorama Ventures achieved Reported EBITDA of $301 million in 1Q23, an increase of 269% QoQ and a decline of 62% YoY. Sales volumes dropped 8% YoY amid the heavy destocking trend that is impacting the chemical industry globally, although volumes rose 5% QoQ as the pace of destocking begins to slow from the peak in 4Q22. With China reopening from pandemic lockdowns and economic activity increasing, there has been marginal improvement in benchmark spreads, albeit below historical levels. In Europe, the warmer-than-expected winter contributed to lower energy prices and alleviated the cost pressures faced last year.

The Group reported an overall decline in Q1 earnings on a year-on-year basis as continued destocking by customers kept sales volumes below consumer consumption levels. CPET posted Reported EBITDA of $142 million, a 74% decrease YoY as sales volumes dropped 9%. Fibers segment achieved Reported EBITDA of $32 million, a decrease of 69% YoY as all three verticals reported declining sales. Integrated Oxides and Derivatives (IOD) segment posted a 4.4% growth in YoY Reported EBITDA to $128 million as volumes rose 4.4% YoY.

Indorama Ventures at the Obernburg site (Germany) will focus on the core markets of tires and automotive safety/airbags and specialties, as well as drive selected product innovations for application in new market segments. Accordingly, the company plans to adjust its capacity at the Obernburg site and cut around 80 of the current 620 total jobs by the end of the year in production and supporting functions.

Stefan Braun, Managing Director of Indorama Ventures at Industrie Center Obernburg, said, “Global competitive pressure in the man-made fibers industry continues. While our customers value us as one of their leading technology partners, particularly in the development and production of nylon yarns, the cost pressure in the production of individual polyester-based yarns has increased continuously in recent years. We are therefore convinced that we have made the right decision to focus on our core competencies to remain successful in the long term.”

The jobs cuts affect both production and administration and sales positions. Representatives of the company and the Works Council together informed employees about the situation on May 4.

The aim is to make the adjustments as acceptable as possible. Braun added, “We are prepared to talk to employees who will reach retirement age soon and who wish to leave the company early.” The company and employee representatives will agree on suitable measures in the coming weeks.

Around EUR 355 million in overall turnover, 350 extruders delivered creating an additional recycling capacity for 1.6 million tons of recycled pellets as a result - these are the figures with which the EREMA Group was able to close the 2022/23 financial year in March.

"With demand for recycled plastics remaining high, the past financial year brought many challenges that we needed to handle," says Manfred Hackl, CEO of EREMA Group GmbH. The challenges included persistent delays in the supply chain and unexpected supplier outages. Logistics and production processes had to be adapted several times as a result. The situation has improved significantly meantime as a result of these measures and more stable supply chains.

The production locations in Austria manufactured 270 extruders and delivered them to customers around the globe. Taking the whole group into consideration, this figure rises to 350 including the extruders from PLASMAC, the Italian subsidiary. The recycled pellet production capacity of all extrusion systems delivered in financial year 2022/23 adds up to around 1.6 million tonnes per year. On top of that there are around 130 additional components and modules such as filter systems and ReFresher anti-odour units.

Recycling innovations for high-quality pellets
K 2022 - the highlight trade fair of the past financial year - saw the EREMA Group launch seven
new recycling systems and components. These included the new INTAREMA® TVEplus® DuaFil® Compact recycling system and the EcoGentle® plasticising unit, which was also newly developed. Thanks to their gentle polymer treatment and significantly lower melt temperature, both extrusion innovations deliver effective advantages in terms of the quality of the melt, recycled pellets, and final product, as well as impressive energy efficiency in post consumer and PET recycling applications. The significance of these innovations for plastics recycling is underlined by the nomination of the DuaFil® Compact technology for one of this year's Plastics Recycling Awards Europe in the category Recycling Machinery Innovation of the Year.
The same applies to the READYMAC 1109 TVE machine made to stock by EREMA Group subsidiary UMAC, as well as to the new ALPHA XS edge trim recycling machine for the inhouse recycling segment made by PLASMAC. The market launch of the deinking system presented at K 2022 by the EREMA Group company KEYCYCLE delivering a throughput of 1,200 kilograms per hour has been a success, as has the commissioning of a further unit sold to a film manufacturer.

40 years of EREMA
The beginning of the new financial year falls almost to the day on EREMA's 40th anniversary. On 14 April 1983, Helmut Bacher, Helmuth Schulz and Georg Wendelin founded EREMA Engineering Recycling Maschinen und Anlagen GesmbH, laying the foundation for the 40-year success story. In celebration, the comapny will hold the event EREMA Discovery Day at the company headquarters on the 1st of June. This event with live insights into the latest post consumer and PET recycling technologies will also see the official opening of the newly built research and development centre.

Shareholders Adopt All Motions Proposed by the Board of Directors

• Distribution of a dividend of CHF 1.50 per share approved
• Remuneration Report 2022 and future remuneration of Board of Directors and Group Executive Committee formally accepted
• All members of the Board of Directors who stood for re-election were elected
• Thomas Oetterli newly appointed to the Board of Directors
• KPMG newly elected as statutory auditors
• Amendments to the Articles of Association approved

On April 20, 2023, 325 shareholders, who represent 66.2% of the share capital, attended the 132nd Annual General Meeting of Rieter Holding Ltd.

Dividend
The shareholders approved the proposal of the Board of Directors to distribute a dividend of CHF 1.50 per share. The dividend for the 2022 financial year will be paid on April 24, 2023.

Annual Report, Financial Statements, Consolidated Financial Statements and Remuneration Report
The shareholders also adopted all other motions proposed by the Board of Directors, namely approval of the annual report, financial and consolidated financial statements for 2022. Moreover, they formally approved the actions of the members of the Board of Directors and those of the Group Executive Committee in the year under review.

By way of a consultative vote, the shareholders also approved the Remuneration Report 2022.

Remuneration of the Members of the Board of Directors and the Group Executive Committee
In two separate binding votes, the proposed maximum total remuneration of the members of the Board of Directors and the Group Executive Committee for the 2024 financial year was approved.

Re-Election of the Members of the Board of Directors
The Chairman of the Board, Bernhard Jucker, and the Directors, Hans-Peter Schwald, Peter Spuhler, Roger Baillod, Carl Illi, Sarah Kreienbühl and Daniel Grieder were confirmed for a further one-year term of office. In addition, Thomas Oetterli was newly elected to the Board of Directors for a term of office.

The members of the Remuneration Committee who were standing for election –
Hans-Peter Schwald, Bernhard Jucker and Sarah Kreienbühl – were likewise re-elected for a one-year term of office.

Election of KPMG as Statutory Auditors
The shareholders also adopted the proposal of the Board of Directors to elect KPMG AG, Zurich, as new statutory auditors for the financial year beginning January 1, 2023.

Amendments to the Articles of Association
The shareholders further approved the proposals of the Board of Directors to amend the Articles of Association of Rieter Holding Ltd., in order to implement the requirements of the reform of the Swiss company law, which came into force on January 1, 2023.

Carbios, a compnay in the development and industrialization of biological technologies for reinventing the life cycle of plastics and textiles, announces its operating and financial results for the year 2022. The financial statements as of December 31, 2022, were approved by the Company’s Board of Directors at their meeting on April 5, 2023.

• Project to build, in France, the world’s first PET biorecycling plant: Progress in line with 2025 unit commissioning target6
• Excellent results from the demonstration plant validating the industrial scale-up of Carbios technology
• Carbios licensing documentation ready for worldwide industrial and commercial deployment
• Long-term exclusive strategic partnership with Novozymes to ensure supply of enzymes at industrial scale for the Reference Unit and all future licensee plants
• Creation of fiber-to-fiber consortium with On, Patagonia, Puma, PVH Corp., and Salomon
• CE-PET research project successfully completed
• Participation in WhiteCycle project co-funded by Horizon Europe and coordinated by Michelin
• Publication of scientific articles in the prestigious Biophysical Journal and in Chemical Reviews
• Carbios hosts world’s first PET Biorecycling Summit
• Carbios publishes first Sustainability Report and outlines objectives for environmental, social and governance (ESG) initiatives
• Carbios joins Ellen MacArthur Foundation’s circular economy network
• €30 million European Investment Bank loan drawn down in 2022
• Group’s cash position of €101 million as of December 31, 2022

The diabetic community has always been a priority for Hologenix, creators of CELLIANT® infrared technology, so the company embarked on an initial study to test the hypothesis that the technology can positively impact diabetic patients with vascular impairment, now published in Journal of Textile Science & Engineering. Another study is underway as well with more research on the horizon.

According to statistics cited in the International Diabetes Federation Diabetes Atlas, 9th edition, globally, close to a half billion people are living with diabetes and that number is expected to increase by more than 50 percent in the next 25 years.
 
The introduction of the study in the Journal of Textile Science & Engineering also reports that diabetic patients frequently suffer from a combination of peripheral neuropathy and peripheral artery disease, which particularly affects their feet. It further states that it has been estimated that the lifetime risk for the development of foot ulcers in diabetic patients can be as high as 25 percent and that the risk of amputation is 10 to 20 times higher than in non-diabetic subjects.
 
The study was performed by Lawrence A. Lavery, D.P.M., M.P.H., a Professor in the Department of Plastic Surgery at UT Southwestern Medical Center. His clinic and research interests involve diabetic foot complications, infections and wound healing, and he participated in the conception, design, implementation and authorship of the Journal of Textile Science & Engineering study.  

CELLIANT technology is a patented process for adding micron-sized thermo-responsive mineral particles to fibers, in this case polyethylene terephthalate (PET) fibers. The resulting CELLIANT yarns were woven into stockings and gloves containing either 82% CELLIANT polyester, 13% nylon and 5% spandex or for the placebo, 82% polyester with no CELLIANT, 13% nylon and 5% spandex. CELLIANT products absorb body heat and re-emit the energy back to the body as infrared energy, which is non-invasive and increases temporary blood flow and cell oxygenation levels in the body.

The objective of the study was to “evaluate changes in transcutaneous oxygen (TcPO2) and peripheral blood flow (laser Doppler, LD) in the hands and feet of diabetic patients with vascular impairment when CELLIANT gloves and stockings are worn.” While there was not a statistically significant result across all subjects, the study did show that some patients wearing CELLIANT stockings for 60 minutes had an increase of as much as 20% in tissue oxygenation and 30% in localized blood flow. According to the study’s conclusion, “the trends that were observed in favor of CELLIANT stockings suggest that a larger well-designed clinical trial should be undertaken and may provide evidence of clinical efficacy in treatment of the diabetic foot.”
 
The study also notes that “There have been no documented or observed side effects of wearing CELLIANT stockings, and they are relatively inexpensive compared to conventional pharmaceutical interventions.”

Hologenix has embarked on a more comprehensive trial, “Study to Evaluate CELLIANT Diabetic Medical Socks to Increase Tissue Oxygenation and Incidence of Complete Wound Closure in Diabetic Foot Wounds” – NCT04709419, which focuses on the impact of CELLIANT technology to potentially improve tissue oxygenation and wound healing outcomes.
 
“We are excited to explore whether future studies of infrared, with its most common biological effects of increased localized blood flow and cellular oxygenation, could result in a breakthrough in diabetic patients with vascular impairment,” said Seth Casden, Hologenix Co-founder and CEO. “We see a huge potential opportunity with this research for helping to fulfill our core mission of improving people’s health and well-being by potentially reducing the impact of diabetes, and we are actively seeking partners to expand our research efforts.”

• Electromagnetically heatable nanomodified stent for the treatment of hollow organ tumours wins second place at the RWTH Innovation Award

Almost every fourth person who dies of cancer has a hollow organ tumour, for example in the bile duct or in the oesophagus. Such a tumour cannot usually be removed surgically. It is only possible to open the hollow organ for a short time using a stent, i.e. a tubeshaped prosthesis. However, the tumour grows back and penetrates the hollow organ through the stent. Ioana Slabu from the Institute of Applied Medical Technology and Benedict Bauer from the Institut für Textiltechnik of RWTH Aachen University have now developed a novel technology for the therapy of hollow organ tumours, which was awarded second place in the RWTH Innovation Award. This involves a polymerstent that contains magnetic nanoparticles. When electromagnetic fields are applied, these nanoparticles lead to a controlled heating of the stent material and thus of the tumour. Because the tumour reacts much more sensitively to heat than healthy tissue, it is destroyed and the hollow organ remains open. Thus, the stent develops a self-cleaning effect.  

Ioana Slabu of the AME explains: "Not only can we drastically reduce treatment costs, but above all we can provide relief for millions of patients worldwide.
 
A manufacturing process and proof of concept for magnetic hyperthermia are already in place. This novel technology has a very high development potential because it can also be used for tumours in other parts of the body such as the prostate, stomach, intestine or urinary bladder or for cardiovascular diseases.  

The AiF/IGF project started under the project title "ProNano" funded by BMWK. Now the approval for the follow-up project "ProNano2" has also been received. The approved project is called: "Validation of the innovation potential of heatable stents for heat-induced treatment of cavity tumours" and is funded by BMBF in course of the VIP+ program. With the Clinic for General, Visceral and Transplantation Surgery of the University Hospital Aachen and the Institute for Technology and Innovation Management at RWTH Aachen University, the consortium is enriched by clinical and economic expertise. Every year, RWTH Aachen University honours particularly innovative university projects with the Innovation Award. Professor Malte Brettel, Prorector for Business and Industry, presented the certificates to four outstanding projects as part of RWTHtransparent.

At the Annual General Meeting of Autoneum Holding Ltd on 24th March 2023, a clear majority of the shareholders approved the introduction of a capital band in the amount of approximately CHF 100 million net proceeds to finance the acquisition of Borgers Automotive. The proposal to waive the payment of a dividend for the 2022 financial year in view of the lower net result was also approved. In addition, Board member Rainer Schmückle as well as CEO Matthias Holzammer were given a farewell.

221 shareholders attended today’s Annual General Meeting of Autoneum Holding Ltd in Winterthur. 66.48 percent of the share capital was represented.

The shareholders approved the Annual Report, the Annual Financial Statements and the Consolidated Financial Statements for 2022. The proposal of the Board of Directors to waive the payment of a dividend for the financial year 2022 due to the lower net result was also approved by the Annual General Meeting.

In addition, the shareholders of Autoneum Holding Ltd granted discharge to all members of the Group Executive Board and the Board of Directors by a large majority of votes.

Chairman Hans-Peter Schwald and the other members of the Board of Directors Liane Hirner, Norbert Indlekofer, Michael Pieper, Oliver Streuli and Ferdinand Stutz were confirmed in office for another year. Hans-Peter Schwald, Norbert Indlekofer, Ferdinand Stutz and Oliver Streuli were re-elected to the Compensation Committee.

The consultative vote on the 2022 remuneration report was approved by 85.55%. The proposals for the remuneration of the Board of Directors and the Group Executive Board for the 2023 financial year as well as the other proposals were also approved by a large majority.

With 99.03%, a clear majority of the shareholders approved a capital band authorizing a capital increase of approximately CHF 100 million net proceeds. The purpose of the capital increase is to partially finance the acquisition of the automotive business of the Borgers Group announced by Autoneum on January 9, 2023. The Annual General Meeting also approved the other proposals of the Board of Directors for partial amendments to the Articles of Association.

Rainer Schmückle did not stand for re-election. He had been Vice Chairman of the Board of Directors, Chairman of the Audit Committee and member of the Strategy and Sustainability Committee since Autoneum became independent in 2011. CEO Matthias Holzammer, who will leave Autoneum for family reasons, was also bid farewell.

At the same time, Hans-Peter Schwald welcomed the new CEO Eelco Spoelder, who will take over the management of the Group from Matthias Holzammer on March 27, 2023: "With Eelco Spoelder, Autoneum gains an accomplished leader with many years of experience in the automotive supply industry. At Faurecia and previously at Continental, Mr. Spoelder has successfully proven that he can ensure strategic continuity and operational excellence even in a difficult market environment. I and the other members of the Board of Directors warmly welcome Eelco Spoelder and look forward to our future cooperation."